Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antibacterial activity against Rhodococcus equi
Assay data:1 Tested
SummaryPubMed Citation
Antimicrobial activity against Rhodococcus equi
Assay data:4 Tested
Antibacterial activity against Rhodococcus equi harboring SPase with valine or isoleucine residue at position 29 by modified CLSI microbroth dilution method
Summary
Antibacterial activity against Rhodococcus equi ATCC 6939 after 16 to 18 hr by broth microdilution method
Assay data:7 Tested
Antibacterial activity against 1 x 10'7 CFU/mL Rhodococcus equi ATCC 6939 in cation-adjusted Mueller Hinton 2 broth after 24 hrs by CLSI broth microdilution method
Assay data:3 Tested
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Ser83Arg mutation selected on 8 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Ser83Arg mutation selected on 6 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Ser83Arg mutation selected on 4 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Ser83Arg mutation selected on 2 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Ser83Ile mutation selected on 16 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Ser83Ile mutation selected on 12 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Ser83Ile mutation selected on 8 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Ser83Ile mutation selected on 4 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Asp87Gly mutation selected on 8 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Asp87Gly mutation selected on 6 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Asp87Gly mutation selected on 4 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Asp87Asn mutation selected on 8 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Asp87Asn mutation selected on 6 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Asp87Asn mutation selected on 4 ug/ml of compound treated culture by broth microdilution method
Antibacterial activity against Rhodococcus equi W5234 harboring GyrA Asp87His mutation selected on 6 ug/ml of compound treated culture by broth microdilution method
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on